Hanson & Doremus Investment Management’s Amedisys AMED Stock Holding History

Hanson & Doremus Investment Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-365	Closed	-$18K	–	443
2016 Q1	$18K	Hold	365	–	–	0.01%	324
2015 Q4	$14K	Hold	365	–	–	0.01%	362
2015 Q3	$14K	Sell	365 -765	-68%	-$32.3K	0.01%	345
2015 Q2	$45K	Sell	1,130 -1,015	-47%	-$31.6K	0.02%	262
2015 Q1	$57K	Sell	2,145 -1,800	-46%	-$50.8K	0.02%	248
2014 Q4	$116K	Sell	3,945 -500	-11%	-$12.3K	0.05%	205
2014 Q3	$90K	Sell	4,445 -885	-17%	-$17.1K	0.04%	214
2014 Q2	$89K	Sell	5,330 -1,110	-17%	-$15.7K	0.04%	215
2014 Q1	$96K	Hold	6,440	–	–	0.05%	210
2013 Q4	$94K	Sell	6,440 -2,950	-31%	-$47.5K	0.05%	208
2013 Q3	$162K	Sell	9,390 -530	-5%	-$7.86K	0.08%	169
2013 Q2	$115K	Buy	+9,920	New	+$114K	0.06%	178

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Hanson & Doremus Investment Management's AMED Position: Q2 2016 in Review

Hanson & Doremus Investment Management sold out of Amedisys (AMED) in Q2 2016, closing a stake of 365 shares — an estimated $18K sold.

Hanson & Doremus Investment Management first reported a position in AMED in Q2 2013 and held it in 12 quarters. The position peaked at $162K in Q3 2013. 168 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

Hanson & Doremus Investment Management reported no remaining Amedisys position as of Q2 2016 after selling out during the quarter.
Hanson & Doremus Investment Management sold 365 Amedisys shares in Q2 2016, an estimated $18K.
Hanson & Doremus Investment Management first reported a position in Amedisys in Q2 2013 and held it in 12 quarters.
Hanson & Doremus Investment Management's Amedisys position peaked at $162K in Q3 2013.
168 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2016, filed 29 Jul 2016.